$268,590
－8%
SNR Advisor CEO; Global Health SEC (Left 11/23)
2023
$213k org
40 hrs/wk
$56k other
--
SNR Advisor CEO; Global Health SEC (Left 11/23) at Foundation for Innovative New Diagnostics
Fiscal year ended December 31, 2023. Published on January 25, 2026.
Total compensation
Daniel Bausch has been listed as an employee of Foundation for Innovative New Diagnostics in Form 990 filings since fiscal year 2022. Total compensation for Daniel Bausch has decreased by 8% from 2022 to 2023.